Search Within

Thoracic Oncology

Formats
  1. Meeting Abstract (1709)
  2. Journal Article (1439)
  3. Review (82)
  4. Editorial (58)
  5. Book Section (35)
  6. Guidelines (25)
  7. Conference Paper (21)
  8. Correspondence (10)
  9. Research Letter (7)
  10. Miscellaneous (6)
  11. Book Whole (2)
Groups
  1. Department of Medicine (3394)
  2. Solid Tumor Oncology Division (3394)
  3. GSK Faculty (1071)
  4. Department of Pathology and Laboratory Medicine (809)
  5. Center for Molecular Imaging and Biotechnology (CMIB) (662)
  6. Human Oncology and Pathogenesis Program (635)

More Groups

People
  1. Mark Kris (872)
  2. Alexander Drilon (637)
  3. Gregory Riely (605)
  4. Charles Rudin (495)
  5. Marc Ladanyi (418)
  6. Matthew Hellmann (412)

More People

Years
  1. 2025 (114)
  2. 2024 (271)
  3. 2023 (273)
  4. 2022 (337)
  5. 2021 (337)
  6. 2020 (258)

More Years

Publications
  1. Journal of Clinical Oncology (703)
  2. Journal of Thoracic Oncology (517)
  3. Annals of Oncology (278)
  4. Clinical Cancer Research (158)
  5. Cancer Research (128)
  6. International Journal of Radiation Oncology, Biology, Physics (89)

More Publications

Publishers
  1. American Society of Clinical Oncology (782)
  2. Elsevier Inc. (738)
  3. American Association for Cancer Research (386)
  4. Oxford University Press (352)
  5. Nature Publishing Group (156)
  6. Elsevier Science, Inc. (79)

More Publishers

Results (3394)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Epigenetic therapy ties MYC depletion to reversing immune evasion and treating lung cancer
    Journal Article

    Topper, M. J.; Vaz, M.; Chiappinelli, K. B.; DeStefano Shields, C. E.; Niknafs, N.; Yen, R. W. C.; Wenzel, A.; Hicks, J.; Ballew, M.; Stone, M.; more...
    Cell (2017)

    Fulltext@MSK | Save
  • Liquid biopsy for ctDNA to revolutionize the care of patients with early stage lung cancers
    Journal Article

    Li, B. T.; Stephens, D.; Chaft, J. E.; Rudin, C. M.; Jones, D. R.; Rusch, V. W.; Rimner, A.; Isbell, J. M.
    Annals of Translational Medicine (2017)

    Fulltext@MSK | Save
  • Factors influencing the utilization of prophylactic cranial irradiation in patients with limited-stage small cell lung cancer
    Journal Article

    Lok, B. H.; Ma, J.; Foster, A.; Perez, C. A.; Shi, W.; Zhang, Z.; Li, B. T.; Rudin, C. M.; Rimner, A.; Wu, A. J.
    Advances in Radiation Oncology (2017)

    Fulltext@MSK | Save
  • Tumor spread through airspaces and histologic subtype predict outcomes following post-operative radiation therapy for locally advanced lung adenocarcinoma
    Meeting Abstract

    Leeman, J. E.; Shepherd, A. F.; Wild, A.; Imber, B. S.; Pei, X.; Gelb, E.; Yorke, E. D.; Travis, W.; Adusumilli, P.; Jones, D.; more...
    International Journal of Radiation Oncology, Biology, Physics (2017)

    Fulltext@MSK | Save
  • [(18)F]PARPi PET as a marker of intratumoral talazoparib level in small cell lung cancer
    Meeting Abstract

    Laird, J. H.; Lok, B. H.; Carney, B.; Kossatz, S.; Ma, J.; Bell, A.; Shah, N.; Sadique, A.; De Stanchina, E.; Reiner, T.; more...
    International Journal of Radiation Oncology, Biology, Physics (2017)

    Fulltext@MSK | Save
  • Proton quad shot RT for palliation in patients with advanced sarcoma
    Meeting Abstract

    Patel, S.; Anderson, E. S.; Kelly, C.; Dickson, M.; Gounder, M.; Keohan, M.; Iqbal, A.; Tap, W. D.; Lee, N.
    International Journal of Radiation Oncology, Biology, Physics (2017)

    Fulltext@MSK | Save
  • Prognostic impact of tumor location and lymph node burden for patients with stage IIIA non-small cell lung cancer receiving postoperative radiation therapy
    Meeting Abstract

    Imber, B. S.; Leeman, J. E.; Shepherd, A. F.; Wild, A.; Pei, X.; Gelb, E.; Chaft, J.; Mychalczak, B. R.; Jones, D.; Isbell, J.; more...
    International Journal of Radiation Oncology, Biology, Physics (2017)

    Fulltext@MSK | Save
  • Lesion response and intracranial control of brain metastases from non-small cell lung cancer after stereotactic radiosurgery or hypofractionated radiation therapy combined with checkpoint inhibitors
    Meeting Abstract

    Imber, B. S.; Hellmann, M. D.; Kris, M. G.; Santomasso, B. D.; Callahan, M. K.; Osorio, J.; Rizvi, H.; Chan, T. A.; Yang, T. J.; Yamada, Y.; more...
    International Journal of Radiation Oncology, Biology, Physics (2017)

    Fulltext@MSK | Save
  • A comparison of trimodality therapy versus definitive concurrent chemoradiation in patients with stage IIIA non-small cell lung cancer
    Meeting Abstract

    Shepherd, A. F.; Leeman, J. E.; Wild, A.; Imber, B. S.; Pei, X.; Gelb, E.; Yorke, E. D.; Isbell, J.; Chaft, J.; Gelblum, D.; more...
    International Journal of Radiation Oncology, Biology, Physics (2017)

    Fulltext@MSK | Save
  • FDG-PET maximum standardized uptake value is prognostic for survival and disease-free survival in stage IIIA-N2 non-small cell lung cancer patients who receive postoperative radiation therapy
    Meeting Abstract

    Wild, A.; Shepherd, A. F.; Leeman, J. E.; Imber, B. S.; Pei, X.; Gelblum, D.; Gelb, E.; Chaft, J.; Jones, D.; Isbell, J.; more...
    International Journal of Radiation Oncology, Biology, Physics (2017)

    Fulltext@MSK | Save